AnalystsEva Fortea Verdejo
Eva Fortea Verdejo's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 8%
#384 out of 5301 analysts
Average Return
+39.67%
Win Rate
71%27 out of 38
Risk vs Reward
Poor
Good

Eva Fortea Verdejo's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Revolution Medicines IncRVMD
+252.49%$46.24$162.99
2025-09-11 -
2026-06-18
Strong Buy
Arcus Biosciences IncRCUS
+149.19%$8.01$19.96
2025-05-07 -
2026-02-12
Strong Buy
Merus NvMRUS
+127.08%$41.25$93.67
2025-02-07 -
2025-09-29
Strong Buy
Merus NvMRUS
+119.01%$42.77$93.67
2025-05-08 -
2025-09-29
Strong Buy
Arcus Biosciences IncRCUS
+115.09%$9.28$19.96
2025-08-07 -
2026-02-12
Strong Buy

Eva Fortea Verdejo's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Nuvalent IncNUVL
2Hold$124.00+0.46%Downgrades
12 days ago
Celcuity IncCELC
2Strong Buy$166.00+89.15%Maintains
18 days ago
Zymeworks IncZYME
5Strong Buy$34.00+46.93%Maintains
a month ago
Exelixis IncEXEL
2Hold$40.00-22.94%Maintains
2 months ago
Kiniksa Pharmaceuticals International PLCKNSA
5Strong Buy$57.00+3.43%Maintains
2 months ago
Relay Therapeutics IncRLAY
5Strong Buy$21.00+32.24%Maintains
2 months ago
Revolution Medicines IncRVMD
3Strong Buy$167.00+2.46%Maintains
2 months ago
Ideaya Biosciences IncIDYA
2Strong Buy$48.00+53.70%Maintains
2 months ago
Bicara Therapeutics IncBCAX
4Hold$16.00-31.12%Maintains
3 months ago
Sutro Biopharma IncSTRO
1Strong Buy$27.00-8.88%Upgrades
3 months ago
Genmab AGMAB
1Strong Buy$40.00+58.29%Initiates Coverage On
4 months ago
Arcus Biosciences IncRCUS
5Hold$23.00-5.39%Downgrades
4 months ago
Immunocore Holdings PLCIMCR
1Strong Buy$60.00+109.79%Initiates Coverage On
8 months ago
Merus NvMRUS
5Hold$97.00+7.78%Downgrades
9 months ago
Iteos Therapeutics IncITOS
7Hold$11.00+8.37%Maintains
10 months ago
Xencor IncXNCR
3Strong Buy$27.00+113.61%Maintains
10 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.